Open Beta
TREN
MetriLume
TREN

US marketsAXGN

SEC-sourced researchBeta

AXGN

Axogen, Inc.

Company comparison ↗

Data passport

CIK
0000805928
Exchange
Nasdaq
Business activity
Electromedical & Electrotherapeutic Apparatus · SIC 3845
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 159,012,000.0000 USD; December 2024: 187,338,000.0000 USD; December 2025: 225,208,000.0000 USD225.2M USD0 USD0December 2023December 2024December 2025
AXGN · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023159,012,000.0000Feb 24, 2026
December 2024187,338,000.0000Feb 24, 2026
December 2025225,208,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025225,208,000.0000-15,703,000.0000812,000.0000221,687,000.000092,840,000.0000Feb 24, 2026
December 2024187,338,000.0000-9,964,000.00004,535,000.0000203,728,000.000099,821,000.0000Feb 24, 2026
December 2023159,012,000.0000-21,716,000.0000-5,716,000.0000——Feb 24, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

63/100
Profitability36
Growth70
Balance sheet58
Cash generation51
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$225.21MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Previous period revenueRevenues$187.34MJan 1, 2024 – Dec 31, 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$15.7MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$812KJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Total assetsAssets$221.69MDec 31, 2025Feb 24, 202610-K
Total liabilitiesLiabilities$92.84MDec 31, 2025Feb 24, 202610-K

New filings

Explore methodology ↗